Delivery Order SPE2DB22D2007-SPE2DB25FJ3EM
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $22,345.60 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 ml vials. The contract, which was competitively awarded without set-aside designation, has a firm fixed price structure and an ultimate completion date of July 21, 2025. Performance will take place at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 11, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials with a contract ceiling value of $10,059.24. This firm fixed-price delivery order, which is set to be completed by August 12, 2025, represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The award was made without set-aside restrictions, indicating it was competitively awarded....
- The Defense Logistics Agency awarded a delivery order valued at $11,624.29 to AmerisourceBergen Drug Corp for the supply of Ferumoxytol 510 mg/17 mL vials. This contract, awarded on August 5, 2025, with an ultimate completion date of August 6, 2025, represents a firm fixed price delivery order with no set-aside designation. The work will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 5, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials, with a ceiling value of $2,702.00 and an ultimate completion date of August 6, 2025. This competitively awarded, firm fixed-price delivery order carries no set-aside designation and will be performed at the vendor's Corporate Office location in Conshohocken, Pennsylvania. The contract represents a continuation of AmerisourceBergen's extensive...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 12, 2025, for the supply of Ferumoxytol 510 mg/17 ml vials valued at $40,827.68. This is a firm fixed-price delivery order with no set-aside designation, reflecting an open competition award. The order is scheduled for completion by August 13, 2025, and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $25,905.78, is for the delivery of Ferumoxytol 510 mg/17 ml vials, a specialty medication. The contract is a Firm Fixed Price Delivery Order with a completion date of February 27, 2025. It is not associated with a set-aside requirement. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
- The Defense Logistics Agency (DLA) awarded a $2,553.24 firm fixed price delivery order to AmerisourceBergen Drug Corp, a for-profit pharmaceutical distribution company, to supply the medication Ferumoxytol 510 mg/17 ml vial. This delivery order is part of a larger indefinite delivery contract (IDC) awarded by DLA to AmerisourceBergen Drug Corp, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $14,126.04, is for the supply of Ferumoxytol 510 mg/17 ml vials to support federal healthcare programs. The order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, for the delivery of Ferumoxytol 510 mg/17 ml vials. The contract, awarded by the Defense Logistics Agency (DLA), is a Firm Fixed Price Delivery Order with a ceiling value of $3,351.60 and a period of performance through February 21, 2025. This contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
- This is a $12,418.16 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565664131 - Ferumoxytol 510 mg/17 ml vial with a completion date of September 4, 2024. The contract does not have a set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and is responsible for providing this critical medical product to support federal healthcare programs and military treatment...
- SPE2DB22D2007Indefinite Delivery Contract
- SPE2DB22D2007-SPE2DB25FJ3EMDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Ferumoxytol 510 mg/17 mL vials, with a contract value of $4,747.76 and an ultimate completion date of July 23, 2025. This is a firm fixed-price delivery order with no set-aside designation, issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The pharmaceutical distributor, headquartered in Conshohocken, Pennsylvania, serves as a critical vendor for federal medical procurement, supplying a comprehensive range of medications and medical supplies to military and veteran healthcare systems. AmerisourceBergen Drug Corp's substantial IDC with DLA Troop Support Medical functions as a global pharmaceutical support vehicle enabling the company to deliver an extensive portfolio of brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support military healthcare programs worldwide. The contract demonstrates the company's capability to fulfill federal procurement requirements through competitive bidding, as evidenced by its consistent receipt of non-set-aside awards across varied product lines and order values. This delivery order for Ferumoxytol, an iron oxide nanoparticle used for iron replacement therapy, represents one of numerous pharmaceutical deliveries AmerisourceBergen provides to the Defense Health Agency and other federal healthcare systems through its comprehensive prime vendor agreement.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.7k | 7/22/25 |